Prevalence of Atelectasis in Critical Trauma Patients

Completed

• Conditions: Pulmonary Atelectasis

• Registration Number: NCT02739854
• Lead Sponsor: Khon Kaen University

Brief Summary

The purpose of this study is to identify the prevalence rate and risk factors for pulmonary complications in patients with critical trauma who intubated and mechanical ventilation.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2016-01-28
• Study Start: 2016-04
• Study First Submitted QC: 2016-04-11
• Study First Posted: 2016-04-15
• Primary Completion: 2017-05
• Study Completion: 2017-05
• Status Verified: 2017-06
• Last Update Submitted: 2017-06-02
• Last Update Posted: 2017-06-05

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 338

Inclusion Criteria

• An inclusion criterion is the traumatic patients (e.g. head injury, blunt chest, blunt abdomen, and fracture of spine; with or without operative, pure or multitrauma) with intubation and mechanical ventilation who admit at this time period will recruit to the study.

Exclusion Criteria

• a patients who admit less than 1 day will be excluded such as sudden death or moving to other ward because of improving conditions, etc.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
number of participants with pulmonary atelectasis	from the date of randomization until the date of first documented of atelectasis, assessed up to 1 years

Secondary Outcome Measures

Name	Time	Method
number of participants with pneumonia	from the date of randomization until the date of first documented of pneumonia, assessed up to 1 years
number of participants with pleural effusion	from the date of randomization until the date of first documented of pleural effusion, assessed up to 1 years
number of participants with adverse events that are related to treatment	from the date of randomization until the date of first documented of pleural effusion, assessed up to 1 years	These data are collected from medical records (i.e. arrhythmia, hypoxia)
number of participants with abnormal laboratory values	from the date of randomization until the date of first documented of pleural effusion, assessed up to 1 years	the laboratory test include arterial blood gases (ABG), Clinical chemistry test (i.e. Blood urea nitrogen, Creatinine, Sodium, Potassium, Phosphorus, Chloride, Magnesium).

Trial Locations

Locations (1)

Khon Kaen University; 🇹🇭 Khon Kaen, Thailand